71 related articles for article (PubMed ID: 29257917)
1. Pharmacological inhibition of S6K1 facilitates platelet activation by enhancing Akt phosphorylation.
Gao W; Wang K; Zhang L; Li J; Liu J; Chen X; Luo X
Platelets; 2019; 30(2):241-250. PubMed ID: 29257917
[TBL] [Abstract][Full Text] [Related]
2. PDK1 regulates platelet activation and arterial thrombosis.
Chen X; Zhang Y; Wang Y; Li D; Zhang L; Wang K; Luo X; Yang Z; Wu Y; Liu J
Blood; 2013 May; 121(18):3718-26. PubMed ID: 23444402
[TBL] [Abstract][Full Text] [Related]
3. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
[TBL] [Abstract][Full Text] [Related]
4. Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis.
Moore SF; Agbani EO; Wersäll A; Poole AW; Williams CM; Zhao X; Li Y; Hutchinson JL; Hunter RW; Hers I
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638997
[TBL] [Abstract][Full Text] [Related]
5. S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.
Aslan JE; Tormoen GW; Loren CP; Pang J; McCarty OJ
Blood; 2011 Sep; 118(11):3129-36. PubMed ID: 21757621
[TBL] [Abstract][Full Text] [Related]
6. Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway.
Wei G; Xu X; Tong H; Wang X; Chen Y; Ding Y; Zhang S; Ju W; Fu C; Li Z; Zeng L; Xu K; Qiao J
Aging (Albany NY); 2020 Apr; 12(9):8151-8166. PubMed ID: 32352928
[TBL] [Abstract][Full Text] [Related]
7. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
Manne BK; Münzer P; Badolia R; Walker-Allgaier B; Campbell RA; Middleton E; Weyrich AS; Kunapuli SP; Borst O; Rondina MT
J Thromb Haemost; 2018 Jun; 16(6):1211-1225. PubMed ID: 29575487
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
9. S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions.
Jiang Q; Zhang X; Dai X; Han S; Wu X; Wang L; Wei W; Zhang N; Xie W; Guo J
Nat Commun; 2022 Mar; 13(1):1548. PubMed ID: 35318320
[TBL] [Abstract][Full Text] [Related]
10. PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses.
Dangelmaier C; Manne BK; Liverani E; Jin J; Bray P; Kunapuli SP
Thromb Haemost; 2014 Mar; 111(3):508-17. PubMed ID: 24352480
[TBL] [Abstract][Full Text] [Related]
11. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
[TBL] [Abstract][Full Text] [Related]
12. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
Liu Y; Fanburg BL
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacological inhibitors demonstrate the role of the tyrosine kinase Pyk2 in adhesion and aggregation of human platelets.
Guidetti GF; Zarà M; Canobbio I; Visconte C; Di Nunzio G; Torti M
Thromb Haemost; 2016 Oct; 116(5):904-917. PubMed ID: 27412718
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CK2 inhibitor (E)-3-(2,3,4,5-tetrabromophenyl)acrylic acid (TBCA) in regulation of platelet function.
Ryu SY; Kim S
Eur J Pharmacol; 2013 Nov; 720(1-3):391-400. PubMed ID: 24140231
[TBL] [Abstract][Full Text] [Related]
17. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
18. 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling.
Zhang B; Cao H; Rao GN
Cancer Res; 2005 Aug; 65(16):7283-91. PubMed ID: 16103079
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
Xu X; Sun J; Song R; Doscas ME; Williamson AJ; Zhou J; Sun J; Jiao X; Liu X; Li Y
Oncotarget; 2017 May; 8(18):30438-30454. PubMed ID: 28389629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
